951024-89-8Relevant academic research and scientific papers
Cross-coupling study of iodo/chloropyridines and 2-chloroquinoline with atom-economic triarylbismuth reagents under Pd-catalysis
Rao, Maddali L.N.,Dhanorkar, Ritesh J.
, p. 338 - 349 (2015/03/04)
This study describes the palladium-catalyzed couplings of iodopyridines, chloropyridines, and chloroquinoline with atom-economic BiAr3 reagents in sub-stoichiometric loadings. Mono-arylations of iodo and chloropyridines produced arylpyridines i
NAPHTHALENE DERIVATIVE
-
Paragraph 0279, (2013/06/27)
The present invention provides compounds which can regulate VCP activity. The present invention provides the compound of formula (I) (R is as defined in the description) or oxides, esters, prodrugs, pharmaceutically acceptable salts or solvates thereof. The compounds can regulate VCP activity, and thus are useful for treating VCP-mediated diseases such as neurodegenerative diseases.
AGENT FOR TREATMENT OF EYE DISEASES
-
Paragraph 0083-0084; 0155-0156, (2013/08/15)
The present invention provides agents effective to treat eye diseases, pharmaceutical compositions comprising them, methods for preparing pharmaceuticals for treatment of eye diseases comprising using the agents, use of the agents in manufacture of pharma
NOVEL IMMUNOMODULATOR AND ANTI INFLAMMATORY COMPOUNDS
-
Page/Page column 38, (2011/11/30)
The present invention provides dihydroorotate dehydrogenase inhibitors of formula (I), methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of diseases or disorders wherein the inhibition of Dihydroorotate dehydrogenase is known to show beneficial effect.
Nitropyridines: VI.* Synthesis of 2-aryl(hetaryl)- and 2,3-polymethylene-5-nitropyridines
Sagitullina,Garkushenko,Vinokurova,Nyrkova,Atavin,Sagitullin
experimental part, p. 1045 - 1049 (2011/02/25)
Previously unknown 2-aryl-, 2-hetaryl-, and 2-cyclopropyl-5-nitropyridines and 2,3-polymethylene-5-nitropyridines were synthesized by reactions of 1-methyl-3,5-dinitropyridin-2(1H)-one with various cyclic and acyclic ketones in the presence of ammonia.
